Dr. Cho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
92 2nd Street
Hackensack, NJ 07601Phone+1 551-996-8297Fax+1 551-996-0575
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 2014
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2011
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology
Certifications & Licensure
- CA State Medical License 2013 - Present
- NJ State Medical License 2022 - 2025
- NY State Medical License 2014 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- 30 citationsHigh progression-free survival after intermediate intensity double unit cord blood transplantation in adultsJuliet N. Barker, Sean M. Devlin, Kristine Naputo, Kelcey Skinner, Molly Maloy
Blood Advances. 2020-12-08 - 20 citationsThird-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant.Susan E Prockop, Aisha Hasan, Ekaterina Doubrovina, Parastoo B Dahi, Irene Rodriguez-Sanchez
The Journal of Clinical Investigation. 2023-05-15 - 367 citationsMicrobiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell TransplantationJonathan U. Peled, Antonio L.C. Gomes, Sean M Devlin, Eric R. Littmann, Ying Taur
The New England Journal of Medicine. 2020-02-26
Abstracts/Posters
- Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell TransplantationChristina Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First RemissionClinically Relevant AbstractChristina Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: